Literature DB >> 25914258

Compensatory fetal membrane mechanisms between biglycan and decorin in inflammation.

Luciana Batalha de Miranda de Araujo1, Casie E Horgan1, Abraham Aron1, Renato V Iozzo2, Beatrice E Lechner1.   

Abstract

Preterm premature rupture of fetal membranes (PPROM) is associated with infection, and is one of the most common causes of preterm birth. Abnormal expression of biglycan and decorin, two extracellular matrix proteoglycans, leads to preterm birth and aberrant fetal membrane morphology and signaling in the mouse. In humans and mice, decorin dysregulation is associated with inflammation in PPROM. We therefore investigated the link between biglycan and decorin and inflammation in fetal membranes using mouse models of intraperitoneal Escherichia coli injections superimposed on genetic biglycan and decorin deficiencies. We assessed outcomes in vivo as well as in vitro using quantitative PCR, Western blotting, and enzyme-linked immunosorbent assays. Our results suggest that biglycan and decorin compensate for each other in the fetal membranes, but lose the ability to do so under inflammation, leading to decreased latency to preterm birth. Furthermore, our findings suggest that biglycan and decorin play discrete roles in fetal membrane signaling pathways during inflammation, leading to changes in the abundance of MMP8 and collagen α1VI, two components of the fetal membrane extracellular matrix that influence the pathophysiology of PPROM. In summary, these findings underline the importance of biglycan and decorin as targets for the manipulation of fetal membrane extracellular matrix stability in the context of inflammation.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25914258      PMCID: PMC4439295          DOI: 10.1002/mrd.22488

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  57 in total

1.  A genetic defect in the biosynthesis of dermatan sulfate proteoglycan: galactosyltransferase I deficiency in fibroblasts from a patient with a progeroid syndrome.

Authors:  E Quentin; A Gladen; L Rodén; H Kresse
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

2.  Aggressive intervention of previable preterm premature rupture of membranes.

Authors:  Ken Miyazaki; Madoka Furuhashi; Kana Yoshida; Kaoru Ishikawa
Journal:  Acta Obstet Gynecol Scand       Date:  2012-06-15       Impact factor: 3.636

3.  Negative regulation of transforming growth factor-beta by the proteoglycan decorin.

Authors:  Y Yamaguchi; D M Mann; E Ruoslahti
Journal:  Nature       Date:  1990-07-19       Impact factor: 49.962

4.  Ehlers-Danlos syndrome: associated with prematurity and premature rupture of foetal membranes; possible increase in incidence.

Authors:  A P Barabas
Journal:  Br Med J       Date:  1966-09-17

5.  A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans.

Authors:  Pedro E Ferrand; Samuel Parry; Mary Sammel; George A Macones; Helena Kuivaniemi; Roberto Romero; Jerome F Strauss
Journal:  Mol Hum Reprod       Date:  2002-05       Impact factor: 4.025

6.  Characterization of chondroitin sulfate and dermatan sulfate proteoglycans of extracellular matrices of human umbilical cord blood vessels and Wharton's jelly.

Authors:  Manojkumar Valiyaveettil; Rajeshwara N Achur; Arivalagan Muthusamy; D Channe Gowda
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

Review 7.  The role of decorin in collagen fibrillogenesis and skin homeostasis.

Authors:  Charles C Reed; Renato V Iozzo
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

8.  Transforming growth factor beta regulates the expression and structure of extracellular matrix chondroitin/dermatan sulfate proteoglycans.

Authors:  A Bassols; J Massagué
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

9.  Proteoglycans of Wharton's jelly.

Authors:  Tomasz Gogiel; Edward Bańkowski; Stefan Jaworski
Journal:  Int J Biochem Cell Biol       Date:  2003-10       Impact factor: 5.085

Review 10.  Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases.

Authors:  Laurent Ameye; Marian F Young
Journal:  Glycobiology       Date:  2002-09       Impact factor: 4.313

View more
  5 in total

Review 1.  Biglycan in the Skeleton.

Authors:  Vardit Kram; Reut Shainer; Priyam Jani; Josephina A N Meester; Bart Loeys; Marian F Young
Journal:  J Histochem Cytochem       Date:  2020-07-06       Impact factor: 2.479

2.  Mechanical Response of Mouse Cervices Lacking Decorin and Biglycan During Pregnancy.

Authors:  Nicole Lee; Lei Shi; Mariano Colon Caraballo; Shanmugasundaram Nallasamy; Mala Mahendroo; Renato V Iozzo; Kristin Myers
Journal:  J Biomech Eng       Date:  2022-06-01       Impact factor: 1.899

3.  Novel regulatory roles of small leucine-rich proteoglycans in remodeling of the uterine cervix in pregnancy.

Authors:  Mariano Colon-Caraballo; Nicole Lee; Shanmugasundaram Nallasamy; Kristin Myers; David Hudson; Renato V Iozzo; Mala Mahendroo
Journal:  Matrix Biol       Date:  2021-12-01       Impact factor: 10.447

4.  Transcriptomic profiling of fetal membranes of mice deficient in biglycan and decorin as a model of preterm birth†.

Authors:  Priyadarshini Pantham; Don L Armstrong; Jonathan Bodnariuc; Owen Haupt; Amy Wagoner Johnson; Lori Underhill; Renato V Iozzo; Beatrice E Lechner; Derek E Wildman
Journal:  Biol Reprod       Date:  2021-03-11       Impact factor: 4.285

5.  Serum Decorin, Biglycan, and Extracellular Matrix Component Expression in Preterm Birth.

Authors:  Jenna M Mennella; Lori A Underhill; Sophia Collis; Geralyn M Lambert-Messerlian; Richard Tucker; Beatrice E Lechner
Journal:  Reprod Sci       Date:  2020-08-17       Impact factor: 3.060

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.